• ثبت نام
    • ورود به سامانه
    مشاهده مورد 
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 19, Issue 2
    • مشاهده مورد
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 19, Issue 2
    • مشاهده مورد
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Calixarbutin: A Novel Calixarene-based Potential Water-soluble Anti-tyrosinase Agent with High Anti-melanoma Activity

    (ندگان)پدیدآور
    Ghafarzadeh, JalalNasuhi Pur, Fazel
    Thumbnail
    دریافت مدرک مشاهده
    FullText
    اندازه فایل: 
    358.4کیلوبایت
    نوع فايل (MIME): 
    PDF
    نوع مدرک
    Text
    Research article
    زبان مدرک
    English
    نمایش کامل رکورد
    چکیده
    Since melanocytes are the origin of melanoma and some skin disorders such as melasma, they are important cells from the perspective of medicinal chemistry. Therefore, a medication that can simultaneously overcome these diseases will be a successful potential therapeutic agent. Arbutin with phenolic structure is a powerful natural anti-tyrosinase agent. Hence, the phenolic structure of this drug, prompted us to design its novel calix [4]arene-based cluster. Therefore, the present study reports the synthesis and in-vitro bio-activities of cyclic tetramer of arbutin in comparison to its simple drug unit as the reference medication. The in-vitro biological results showed amplified anti-tyrosinase (6-fold) and anti-melanoma (27-fold) activities, in addition to more aqueous solubility (8-fold) for this cluster in relation to arbutin. Therefore, compared to arbutin, more bioactive cluster can be considered as a novel water-soluble melanogenesis inhibitor with high anti-melanoma activity.
    کلید واژگان
    Anti-tyrosinase
    anti-melanoma
    arbutin
    Calixarene
    Cluster
    Medicinal chemistry

    شماره نشریه
    2
    تاریخ نشر
    2020-06-01
    1399-03-12
    ناشر
    School of Pharmacy, Shahid Beheshti University of Medical Sciences
    سازمان پدید آورنده
    Deputy of Food and Drug Administration, Urmia University of Medical Sciences, Urmia, Iran.
    Health Technology Incubation Center, Urmia University of Medical Sciences, Urmia, Iran.

    شاپا
    1735-0328
    1726-6890
    URI
    https://dx.doi.org/10.22037/ijpr.2020.112506.13798
    http://ijpr.sbmu.ac.ir/article_1101019.html
    https://iranjournals.nlai.ir/handle/123456789/312315

    مرور

    همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

    حساب من

    ورود به سامانهثبت نام

    آمار

    مشاهده آمار استفاده

    تازه ترین ها

    تازه ترین مدارک
    © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
    تماس با ما | ارسال بازخورد
    قدرت یافته توسطسیناوب